Brevan Howard Capital Management’s Insmed INSM Stock Holding History

Brevan Howard Capital Management’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$576K	Buy	+3,521	New	+$541K	0.01%	1213
2025 Q4	–	Sell	-294,047	Closed	-$42.3M	–	2037
2025 Q3	$42.3M	Buy	294,047 +91,453	+45%	+$11.2M	0.19%	45
2025 Q2	$20.4M	Buy	+202,594	New	+$15.5M	0.12%	88
2024 Q3	–	Sell	-6,127	Closed	-$411K	–	1284
2024 Q2	$411K	Sell	6,127 -18,446	-75%	-$715K	﹤0.01%	673
2024 Q1	$667K	Buy	24,573 +18,112	+280%	+$507K	0.01%	372
2023 Q4	$200K	Buy	+6,461	New	+$168K	﹤0.01%	885

Other funds holding INSM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Brevan Howard Capital Management's INSM Position: Q1 2026 in Review

Brevan Howard Capital Management opened a new position in Insmed (INSM) in Q1 2026: 3,521 shares worth $576K. The stake represents 0.01% of the portfolio and ranks #1213 among its holdings. This is a return to the name: Brevan Howard Capital Management previously reported a position in INSM as recently as Q3 2025.

Brevan Howard Capital Management first reported a position in INSM in Q4 2023 and has held it in 6 quarters since. The position peaked at $42.3M in Q3 2025. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

Brevan Howard Capital Management held 3,521 shares of Insmed worth $576K as of Q1 2026.
Insmed was a new Brevan Howard Capital Management position in Q1 2026.
Insmed made up 0.01% of Brevan Howard Capital Management's portfolio in Q1 2026, its #1213 holding.
Brevan Howard Capital Management first reported a position in Insmed in Q4 2023 and has held it in 6 quarters since.
Brevan Howard Capital Management's Insmed position peaked at $42.3M in Q3 2025.
669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.